Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/29/2003CN1451662A Nucleotide specific to O-antigen of shigella boydii I and Bacillus coli 0149
10/29/2003CN1125985C Test method for dandwich type determination of mite antigen in test sample
10/29/2003CN1125984C Self-provided assay device and method
10/29/2003CN1125983C Analytical device for membrane based assays
10/29/2003CN1125880C Method for processing mycobacteria
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/29/2003CN1125826C Hepatitis E virus gene sequence and its application
10/29/2003CA2382971A1 Double sleeve soil tester
10/28/2003US6639401 Contactless, transformer-based measurement of the resistivity of materials
10/28/2003US6639130 Purified DNA encoding polypeptide having at least 50% identity of arabidopsis C-14
10/28/2003US6639123 Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
10/28/2003US6639078 Assays for ligands for nuclear receptors
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639057 Monoclonal antibody against human telomerase catalytic subunit
10/28/2003US6639053 Screening using this gene or this RNA polymerase protein for inhibitors
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638769 Analysis method and cuvette therefor
10/28/2003US6638761 Thermal cycling device with mechanism for ejecting sample well trays
10/28/2003US6638760 Method and apparatus for flow-through hybridization
10/28/2003US6638752 Biodetectors targeted to specific ligands
10/28/2003US6638747 Isolated polypeptide having specified amino acid sequence
10/28/2003US6638745 Antiinflammatory agents, anticarcinogenic agents; arteriosclerosis, psoriasis; gene therapy, diagnosis; genetic engineering
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638728 Polymeric streptavidin, avidin or deglycosylated avidin
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638726 Contacting test compound to cell expressing a polycystin- 2 protein; measuring adherence to type I collagen coated substrate; genetic engineering
10/28/2003US6638725 Method for assaying receptor binding property and reagent for the assay
10/28/2003US6638723 Method for diagnosing autoimmune diseases
10/28/2003US6638722 Amplifying in mixture comprising DNA sample, first primer comprising random sequence of nucleotides at its 3' end and generic sequence 5' of random nucleotides, second primer comprising generic sequence only, heat stable DNA polymerase
10/28/2003US6638719 Genotyping biallelic markers
10/28/2003US6638717 Detecting an isolating duplicated nucleotide sequences; obtain random sample of nucleotide sequences, immobilize sample on microarrays, hybridize probes, detect hybridized probes, determine sequence of nucleotide segments
10/28/2003US6638711 Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638508 Drug delivery; therapy for liver disorders
10/28/2003US6638507 Antigen binding site of antibody; encoded by nucleic acids; diagnostic kits
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6638480 Determination of total dissolved solids in sample; obtain sample, incubate with color indicator, monitor for color adjustment, determination of dissolved solid
10/28/2003US6638427 Waste water treatment method being able to treat surface active agent, nitrogen, hydrogen peroxide and phosphor with high efficiency
10/28/2003US6638421 Water treatment control system using fluorescence analyzer
10/28/2003US6638416 Hydrogen sensor includes a pump cell and a measuring cell; hydrogen diffusion through the diffusion-limiting barrier is controlled by a Knudsen diffusion mechanism at higher hydrogen concentrations; use in fuel cell applications
10/28/2003US6638415 Antioxidant sensor
10/28/2003US6638406 Capable of detecting hydrocarbon in a living environment and hydrocarbon in exhaust gas from an automobile engine, heater, and catalytic combustion equipment, and can be used for combustion control(leanburn) of a combustion engine
10/28/2003US6637305 Apparatus for machining composite material test specimens
10/28/2003US6637256 Gas sensor and manufacturing method for the same
10/28/2003US6637253 Hydrogen collection and detection
10/28/2003CA2319112C Use of ribozymes for functionating genes
10/28/2003CA2174212C Assay to detect hcv receptor binding
10/28/2003CA2153898C Method for generating single-stranded dna molecules
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/23/2003WO2003088141A2 Device for event detection and method for measuring the activity of neuronal networks
10/23/2003WO2003088125A2 System and method for integrated computer-aided molecular discovery
10/23/2003WO2003088090A2 System and method for data analysis, manipulation, and visualization
10/23/2003WO2003087993A2 Oligonucleotide probes for genosensor chips
10/23/2003WO2003087899A1 Method of detecting an analyte in a fluid
10/23/2003WO2003087844A1 A method for identifying at risk cardiovascular disease patients
10/23/2003WO2003087843A2 Diagnostics and therapeutics for diseases associated with mas related gene f (mrgf)
10/23/2003WO2003087842A1 Method for the identification of modulators of a secretase activity
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087839A1 Method for characterising analytes
10/23/2003WO2003087838A2 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
10/23/2003WO2003087836A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003WO2003087835A1 Haptoglobin fragments diagnostic of alzheimers disease
10/23/2003WO2003087834A2 High throughput analysis of recombinant proteins in multi-well plates
10/23/2003WO2003087833A2 A marker for measuring liver cirrhosis
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087831A2 Proteins involved in breast cancer
10/23/2003WO2003087830A2 Timp-1 as a postoperative marker for recurrent cancer
10/23/2003WO2003087829A2 Human papilloma virus detection with dna microarray
10/23/2003WO2003087827A2 Multi-parameter assays including analysis discs and methods relating thereto
10/23/2003WO2003087826A1 Method of analyzing molecule and molecule analyzer
10/23/2003WO2003087825A2 Method, system and kit for detecting an analyte in a sample
10/23/2003WO2003087823A1 Method for immobilizing molecules on surfaces
10/23/2003WO2003087822A2 Sensitive immunochromatographic assay
10/23/2003WO2003087821A2 Method for cleaving and deglycosylating antibodies to promote ligand binding
10/23/2003WO2003087820A1 Method of examining comp failure
10/23/2003WO2003087819A1 Methods for determining levels of human b-type natriuretic peptide precursors
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087817A2 Device and method for measuring coagulation time and platelet activity
10/23/2003WO2003087816A1 Crystals and structures of pak4kd kinase pak4kd
10/23/2003WO2003087815A2 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
10/23/2003WO2003087814A1 Method and apparatus for measuring amount of coating on paper web
10/23/2003WO2003087813A1 Method for discriminating organic agricultural products from conventional agricultural products by using nitrogen isotope index
10/23/2003WO2003087811A1 Apparatus for analyzing mixtures of gases
10/23/2003WO2003087805A2 Method for efficiently computing the mass of modified peptides for mass spectrometry data-based identification
10/23/2003WO2003087804A1 Method of nondestructive examination of chromium-containing nickel-based alloy for grain boundary corrosion and examination apparatus
10/23/2003WO2003087798A1 Sensor cell, biosensor, capacitive device manufacturing method, biological reaction detection method, and gene analyzing method
10/23/2003WO2003087783A1 Analyte sensor
10/23/2003WO2003087775A2 Monitoring blood substances using self-sampled tears
10/23/2003WO2003087774A2 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
10/23/2003WO2003087772A2 Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells
10/23/2003WO2003087771A2 Method for making a molecularly smooth surface
10/23/2003WO2003087769A2 Method for identifying modulators of ion channels
10/23/2003WO2003087768A2 Targets for therapeutic intervention identified in the mitochondrial proteome
10/23/2003WO2003087766A2 Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
10/23/2003WO2003087764A2 Connection of cells to substrates using association pairs
10/23/2003WO2003087761A2 Molecular profiling of disease and therapeutic response using phospho-specific antibodies
10/23/2003WO2003087760A2 Methods for detecting bcr-abl signaling activity in tissues using phospho- specific antibodies